Literature DB >> 10940870

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.

M B Lutz1, R M Suri, M Niimi, A L Ogilvie, N A Kukutsch, S Rössner, G Schuler, J M Austyn.   

Abstract

Dendritic cells (DC) were cultured from mouse bone marrow (BM) progenitors in low concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF) (GM(lo) DC) by two different protocols. The phenotype and functional properties of these GM(lo) DC were compared to those of standard BM-DC cultures generated in high concentrations of GM-CSF (GM(hi) DC) or in low GM-CSF plus IL-4 (GM(lo)/IL-4 DC). An effect of IL-4 on maturation was observed only at low but not high doses of GM-CSF. Compared to mature DC, GM(lo) DC were phenotypically immature, weak stimulators of allogeneic and peptide-specific T cell responses, but substantially more potent in presentation of native protein. Immature GM(lo) DC were resistant to maturation by lipopolysaccharide, TNF-alpha or anti-CD40 monoclonal antibodies, as the expression of co-stimulatory molecules was not increased, and stimulatory activity in oxidative mitogenesis was not enhanced. These maturation-resistant immature GM(lo) DC induced T cell unresponsiveness in vitro and in vivo. GM(lo) DC also prolonged haplotype-specific cardiac allograft survival (from 8 days to >100 days median survival time) when they were administered 7 days (but not 3, 14 or 28 days) before transplantation. Our findings may have important implications for future studies in T cell tolerance induction in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940870     DOI: 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  123 in total

1.  High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach.

Authors:  B M Foxwell; S Yoshimura; J Bondeson; F M Brennan; M Feldmann
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.

Authors:  Jonathan J Cho; Joshua M Stewart; Theodore T Drashansky; Maigan A Brusko; Ashley N Zuniga; Kyle J Lorentsen; Benjamin G Keselowsky; Dorina Avram
Journal:  Biomaterials       Date:  2017-07-24       Impact factor: 12.479

3.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

Authors:  V Bronte; E Apolloni; A Cabrelle; R Ronca; P Serafini; P Zamboni; N P Restifo; P Zanovello
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 4.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

Review 5.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 6.  Alternatives to immunosuppressive drugs in human islet transplantation.

Authors:  Alison Anne Cotterell; Norma Sue Kenyon
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 7.  Routes to transplant tolerance versus rejection; the role of cytokines.

Authors:  Patrick T Walsh; Terry B Strom; Laurence A Turka
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

8.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

9.  PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation.

Authors:  Xing-Wei Xu; Bo-Wen Ding; Chuan-Rong Zhu; Wu Ji; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Authors:  Dianne L Commeren; Peter L Van Soest; Khalil Karimi; Bob Löwenberg; Jan J Cornelissen; Eric Braakman
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.